Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Tilray Brands Inc (TLRY) vs Veritone Inc (VERI) Price & Performance

Tilray Brands IncTrade
Veritone IncTrade

Price performance (Past 24H)

Key statistics

Tilray Brands Inc vs Veritone Inc — how do they compare? Tilray Brands Inc trades at $3.49 (market cap $530.54M), while Veritone Inc trades at $0.58 (market cap $59.46M). The key difference: Tilray Brands Inc is far larger — about 8.9× Veritone Inc's market cap, and Veritone Inc is more actively traded (15,523,164 versus 9,099,075). Which is the better fit depends on your goals — on Pluang, investors hold Tilray Brands Inc for 31 Days and Veritone Inc for 12 Days on average.

TLRYVERI
Market Cap
$530.54M$59.46M
Volume
9,099,07515,523,164
Sector
HealthTechnology
52-Week High
$21.00$8.39
52-Week Low
$3.57$0.59
Typical Hold Time
31 Days12 Days
Enterprise Value
$684.46M$94.86M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Tilray Brands Inc

TLRY trades at $3.465, down 6.73% on the day and near 52-week lows, reflecting persistent bearish sentiment. The stock shows weak technical momentum with oversold RSI readings but faces fundamental challenges including consecutive quarterly earnings misses, negative profit margins, and declining revenue growth. Recent news highlights the company's struggles with profitability despite record annual revenue, with shares down over 50% year-to-date as investors question the cannabis company's path to sustainable growth.

TLRY presents a high-risk opportunity with significant downside protection from its low P/B ratio of 0.33, but requires substantial operational improvement to justify investment. The bullish case hinges on potential marijuana reform catalysts and BrewDog integration progress, while risks include ongoing losses, competitive pressures, and execution challenges in a volatile regulatory environment.

Veritone Inc

Veritone (VERI) trades at $0.61, down 11.76% in the last 24 hours, reflecting bearish technical signals. The company reported a net loss of $111.73 million in 2025, with negative profit margins and cash flow challenges, though revenue remains near $92 million. Recent news includes a $15 million equity offering and partnerships, but legal investigations and persistent losses weigh on sentiment.

The outlook is highly speculative, with a consensus price target of $3.75 suggesting significant upside if the company achieves profitability. However, high execution risk, cash burn, and legal overhangs present substantial downside, making the stock suitable only for risk-tolerant investors betting on a turnaround.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TLRY
100% Buy0% Sell
Avg holding period · 31 Days
VERI
7% Buy93% Sell
Avg holding period · 12 Days

Top news

Latest headlines on both assets

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY →

About Veritone Inc

Veritone is a leading provider of enterprise AI software and solutions, centered on its proprietary AI operating system, aiWARE™. The platform orchestrates a vast ecosystem of machine learning models to transform unstructured data—such as audio, video, and text—into actionable intelligence. Serving the media, entertainment, and public sectors, Veritone is a critical infrastructure partner for organizations looking to monetize data archives and operationalize AI at scale.

Read more on VERI →